Stock Events

Stock Events

Denali Therapeutics (DNLI) Q2 2026 Earnings

May 7Confirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.78

-0.75

-0.72

-0.69

Details

Expected EPS

-0.723331

Actual EPS

-0.69

Surprise EPS

0.03

Surprise Percent

+4.61%

Description

⁨Denali Therapeutics⁩ (⁦DNLI⁩) has reported earnings of ⁦-0.69⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.